drugset / Trial / NCT02946437
Sevoflurane in Subarachnoidal Haemorrhage
RandomizedParallel-groupOpen-labelTreatment
Summary
Feasibility and safety of short term application of sevoflurane in patients with SAH treated with aneurysm coiling or clipping in the setting of a neurointensive care unit.
Timeline
- Start
- 2015-11-01
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Midazolam | Small molecule | 0.03 mg/kg | Intravenous |
| Comparator | Midazolam | Small molecule | 0.2 mg/kg | Intravenous |
| Comparator | Propofol | Small molecule | 0.3 mg/kg | Intravenous |
| Comparator | Propofol | Small molecule | 4 mg/kg | Intravenous |
| Subject | Sevoflurane | Other / unclassified | 0.5 % | Inhaled |
| Subject | Sevoflurane | Other / unclassified | 1.5 % | Inhaled |